Related Experiment Video
Updated: Mar 29, 2026
09:02
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
22.7K
Metabolism pathways in chronic lymphocytic leukemia
Uri Rozovski1,2, Inbal Hazan-Halevy3, Merav Barzilai2,4
1a Division of Hematology , Davidoff Cancer Center, Rabin Medical Center , Petach Tikva , Israel ;
Leukemia & Lymphoma
|December 9, 2015
Summary
Chronic lymphocytic leukemia (CLL) cells uniquely store lipids and use free fatty acids (FFA) for energy, independent of direct genetic mutations. STAT3 activation drives this altered lipid metabolism, offering potential therapeutic targets.
Area of Science:
- Biochemistry
- Oncology
- Cell Biology
Background:
- Chronic lymphocytic leukemia (CLL) cells exhibit distinct metabolic characteristics compared to normal B lymphocytes.
- CLL cells, similar to adipocytes, accumulate lipids and rely on free fatty acids (FFA) for energy production.
Purpose of the Study:
- To review the evidence for altered lipid metabolism in CLL cells.
- To explore the role of STAT3 activation and microRNA-125 downregulation in CLL cell metabolism.
- To discuss potential therapeutic strategies targeting lipid metabolism in CLL.
Main Methods:
- Literature review of studies on CLL cell metabolism.
- Analysis of the role of signaling pathways (STAT3) and microRNAs in metabolic reprogramming.
- Examination of mitochondrial activity and reactive oxygen species (ROS) production in CLL cells.
Main Results:
- CLL cells demonstrate significant alterations in lipid metabolism, utilizing FFA for energy.
- Genetic mutations in CLL do not appear to directly drive metabolic reprogramming.
- Constitutive STAT3 activation increases lipoprotein lipase (LPL) levels, promoting FFA utilization.
Conclusions:
- CLL cell metabolism is characterized by increased lipid utilization and mitochondrial activity.
- STAT3 activation and microRNA-125 downregulation are key factors in CLL cell metabolic reprogramming.
- Targeting lipid metabolism pathways presents a promising therapeutic avenue for CLL treatment.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
9.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
01:27Disorders of Leukocytes
2.4K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.4K
01:19Interactions Between Signaling Pathways
7.9K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
01:18Lymphoid Cells and Tissues
3.8K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
3.8K